Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
Great news! The Centers for Medicare and Medicaid Services (CMS) has increased payment for peripheral IVL procedures. The increases apply to procedures performed in anatomical locations above the knee in a hospital outpatient setting. The changes go into effect on January 1, 2022.
Topics: Peripheral IVL, Peripheral Clinical Data, Reimbursement
Transfemoral access represents the gold standard for TAVI, with TF access showing a significant reduction in complications and mortality in comparison to alternative access strategies, which add additional complexity and risk to the procedure. Despite the wide acceptance that the transfemoral route provides the safest access for patients, the approach can be hindered by calcified iliac arteries inhibiting delivery of large bore devices by restricting the luminal diameter and reducing vessel compliance. If calcium is not treated adequately prior to TAVI delivery, this can lead to complications such as flow limiting dissection, vessel rupture and unsuccessful delivery of the implant.
Topics: Peripheral IVL, Peripheral Clinical Data
Winter is coming… and fast but before we enter the final home stretch of the year, let’s recount the milestones of the recent quarter in the latest edition of the PulsePoint Newsletter. Shockwave hit the ground running this quarter by bringing on various IVL experts from across the globe to discuss all things calcium on the ChalkTalk Podcast Series. Shockwave also made headlines in CathLab Digest with several physician-authored perspectives about the role of the technology in clinical practice. And it was great to finally get back to live, in-person conferences like VIVA ’21, where the results from the first 752 patients in the Disrupt PAD III Observational Study were presented. Catch up on what you may have missed and don’t forget watch the CalciumMasterclass.com series finale!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, PulsePoint Newsletter
On Thursday, November 18, join us and six IVL experts at VEITH 2021 to hear how Intravascular Lithotripsy (IVL) works across multiple vessel beds.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data
Calcium causes a magnitude of problems in EVAR and TEVAR procedures. Calcium can inhibit stent graft delivery leading to significant dissection or perforation of the iliac arteries. Calcium can also affect expansion of iliac limbs leading to increased risk of under expansion and stent graft thrombosis.
Watch as Dr. Stefano Fazzini, Tor Vergata University Hospital, Italy walks you through how Shockwave IVL can help alleviate access challenges while minimizing complications and the need for secondary interventions.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data
We’ve all heard that Shockwave IVL doesn’t work in eccentric calcium… well that’s just a myth. Watch Prof. Andrew Holden’s presentation from CIRSE21 as he walks you through IVL’s eccentric vs concentric lesion data subset from the PADIII Observational Study and learn how this myth can well and truly be dispelled.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data, Treating Different Ca++ Morphologies
In anticipation of TCT starting in early November, we had quick conversation with Shockwave Medical’s Chief Medical Officer, Dr. Keith Dawkins, about IVL’s presence at the meeting and the most interesting data coming out. Hope you enjoy his perspective!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
Explore the new world of Shockwave with Paul Higginbottom, Director of Sales in the UK and France, in ChalkTalk episode five. With over 10+ years in the medical device industry and a complex PCI background, Paul recounts the joys of his career journey but explains how the unique attributes of IVL and start-up environment are what compelled him to join Shockwave at the beginning of this year. He provides insights into Shockwave’s culture, shares challenges that he has faced already, and talks about going direct in the UK and France. Listen to catch Paul’s first interactions with physicians and their surprising feedback – enjoy!
Topics: Coronary IVL, Peripheral IVL, IVL Technology, SWAV News, ChalkTalk Podcast
Dr. Ehrin Armstrong presented the interim results from the first 752 patients in the Disrupt PAD III Observational Study (OS), reinforcing the consistency of IVL's unique mechanism of action to safely and effectively modify superficial and deep calcium across multiple vessel beds, lesion types and CLI patients.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data
If you are attending VIVA21, you may not be dealing cards, but you’re likely dealing with peripheral artery calcium. So join Dr. Sahil Parikh, Dr. Ehrin Armstrong, Dr. Venita Chandra and Dr. Peter Soukas at 12pm Pacific Time on Wednesday, October 6th in the Bandol Room to make sure you don’t gamble with your calcium strategy. Listen to the esteemed panel during the Shockwave Medical Symposium and you learn how Intravascular Lithotripsy (IVL) can help you beat the odds.
Topics: Peripheral IVL, Peripheral Conferences, Peripheral Clinical Data
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
